Floatz logo

HUMAN IMMUNOGLOBULINS

CML (Chronic Myelogenous Leukemia)

Center for International Blood and Marrow Transplant Researchother_biologicalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the CML (Chronic Myelogenous Leukemia) cohort.

Asset / SponsorPhaseRating
TACROLIMUS
Center for International Blood and Marrow Transplant Research
Phase 2B
Lorazepam
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Ptcy
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Keppra
Center for International Blood and Marrow Transplant Research
Phase 2CCC
ABATACEPT RECOMBINANT
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Fosphenytoin
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Mvstr
National Heart, Lung, and Blood Institute (NHLBI)
Phase 1CC
Mvst
National Heart, Lung, and Blood Institute (NHLBI)
Phase 1CC

Same molecule, other indications

HUMAN IMMUNOGLOBULINS is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
70 / 100
View asset →
Post-Polio SyndromeDormant
BB
Indicative ·
67 / 100
View asset →
epilepsyDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →